EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark XUNDRIA was filed as Word mark on 12/20/2010 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/13/2011.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 009610254 |
| Application date | December 20, 2010 |
| Publication date | April 5, 2011 |
| Entry date | July 13, 2011 |
| Expiration date | December 20, 2020 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Widenmayerstr. 10
80538 München
DE
goods and services
5
Pharmaceutical preparations, namely pharmaceutical preparations for the treatment of cancer/oncology; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer, cardiovascular diseases, cholesterol disorders, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotics; antidepressants; pharmaceutical preparations for use in the prevention and treatment of anxiety spectrum disorders, atherosclerosis, Alzheimer's; pharmaceutical preparations for use in the treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease, systemic lupus erythematosus, and ankylosing spondylitis disease; pharmaceutical preparations for use in the treatment of psoriasis and psoriatic arthritis; pharmaceutical preparations for use in the treatment of autoimmune disorders; pharmaceutical preparations
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 25, 2019 | Change Representative, Published | ||
| December 20, 2018 | Change Representative, Published |
ID: 11009610254